Form 8-K

0001171843-22-003649.txt : 20220512 0001171843-22-003649.hdr.sgml : 20220512 20220512172016 ACCESSION NUMBER: 0001171843-22-003649 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220512 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220512 DATE AS OF CHANGE: 20220512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Predictive Oncology Inc. CENTRAL INDEX KEY: 0001446159 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 331007393 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36790 FILM NUMBER: 22919068 BUSINESS ADDRESS: STREET 1: 2915 COMMERS DRIVE, STREET 2: SUITE 900 CITY: EAGAN STATE: MN ZIP: 55121 BUSINESS PHONE: 651-389-4800 MAIL ADDRESS: STREET 1: 2915 COMMERS DRIVE, STREET 2: SUITE 900 CITY: EAGAN STATE: MN ZIP: 55121 FORMER COMPANY: FORMER CONFORMED NAME: Precision Therapeutics Inc. DATE OF NAME CHANGE: 20180314 FORMER COMPANY: FORMER CONFORMED NAME: Precision Therapeutic Inc. DATE OF NAME CHANGE: 20180208 FORMER COMPANY: FORMER CONFORMED NAME: Skyline Medical Inc. DATE OF NAME CHANGE: 20130807 8-K 1 f8k_051222.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 12, 2022

_______________________________

Predictive Oncology Inc.

(Exact name of registrant as specified in its charter)

_______________________________

Delaware	001-36790	33-1007393
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

2915 Commers Drive, Suite 900

Eagan, Minnesota 55121

(Address of Principal Executive Offices) (Zip Code)

(651) 389-4800

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, $0.01 par value	POAI	Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On May 12, 2022, Predictive Oncology Inc. issued a press release attached hereto as Exhibit 99.1 announcing its financial results for the three months ended March 31, 2022.

Item 9.01. Financial Statements and Exhibits.

(a) Not applicable.

(b) Not applicable.

(d) Exhibits

Exhibit No.		Description

99.1		Press Release dated May 12, 2022
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Predictive Oncology Inc.


Date: May 12, 2022	By:	/s/ Bob Myers
		Bob Myers
		Chief Financial Officer

EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling

EXHIBIT 99.1

Predictive Oncology Reports First Quarter Financial Results

EAGAN, Minn., May 12, 2022 (GLOBE NEWSWIRE) -- The financial results from the first quarter we believe depicts a solid potential for growth in the upcoming period, in accordance with the report by Predictive Oncology Inc. (NASDAQ: POAI) today, disclosing the results for the quarter ended March 31, 2022. The consolidated results of Predictive Oncology’s reportable segments included recognized revenue of $314,568 for the quarter.

The artificial intelligence (AI) and data-driven discovery services entity also reported an update on its business operations. Highlights from the quarter included:

Discovery 21 and PeDAL® platform validated as Predictive Oncology moves ahead with commercialization.
Cash and equivalents were $25 million as of March 31, 2022.
The company has not reported any long-term debt obligations in its capital structure.
Predictive Oncology’s reported loss per common share was reduced to $0.05, as compared to $0.11 for the comparable period in 2021.

“We are extremely excited that our technology provides a significant competitive advantage to our business offerings. Our CRO services business applies PeDAL to address a range of needs from discovery through clinical and translational research, to clinical trials and diagnostic development and validation. We believe this market segment has significant growth potential for Predictive Oncology and we believe we are differentiated from traditional CRO’s and other Artificial Intelligence companies through this unique asset,” said J. Melville Engle, the Company’s Chairman and Chief Executive Officer.

Q1 2022 Financial results

Predictive Oncology reported consolidated revenue of $314,568 for the quarter, as compared to $280,317 for the same quarter in 2021. The positive change was mainly due to an increase of 6% in the Skyline segment (STREAMWAY® System product sales) and initial revenue from the zPREDICTA segment.

The new zPREDICTA segment has an encouraging sales pipeline, including additional revenue from current transactions that are expected to be recognized in the next several quarters.

General and administrative expenses decreased from $3.3 million on March 31, 2021, to $2.4 million in on March 31, 2022. This represents a positive change between quarters resulting from decreased retirement, legal and other professional expenses.

The gross profit margin remained steady at approximately 65% for March 31, 2022, and March 2021, respectively.

Operations expense increased by $316,259 to $891,071 in the three months ended March 31, 2022, as compared to the comparable quarter of 2021, mainly due to higher costs related to staff from our zPREDICTA division acquired in late 2021.

Net cash used in operating activities was $3,093,696 and $3,322,091 for the three months ended March 31, 2022, and March 31, 2021, respectively. Cash used in operating activities decreased in March 2022 as compared to the comparable period of 2021, because of the decrease in cash used for working capital and lower operating costs.

The quarterly sales and marketing expenses of the company have increased by $189,826 for the quarter to $304,467, as compared to the comparable period in 2021. This increment was principally a direct result of the strategic decision to focus on the company’s commercialization efforts in 2022, which will be largely focused on the Helomics and zPREDICTA products. These factors increased the company’s expenses for corporate development, sales staff, marketing and public relations.

About Predictive Oncology Inc.

Predictive Oncology (NASDAQ: POAI) operates through four segments (Skyline, Helomics, zPREDICTA and Soluble), which covers five subsidiaries: Helomics, TumorGenesis, Skyline Medical, zPREDICTA and Soluble Biotech.

TumorGenesis is the company’s arm for research and development for zPREDICTA, Soluble Biotech and Helomics. This subsidiary is also involved in media which aid cancer cells grow outside the body of patients and preserve their proteomic and RNA/DNA signatures. Helomics Holding Corporation is involved in applying artificial intelligence (“AI”) in the company’s precision medicine business, to offer AI-driven predictive models of tumor drug response to enhance clinical results for patients and to aid diagnostic, biotech and pharmaceutical industries in the new personalized diagnostics and drugs development. Skyline Medical Inc. (“Skyline Medical”), the STREAMWAY System is a fully automated wall-mounted system, which is utilized to dispose of an unlimited quantity of suction fluid offering continuous performance for medical practitioners while effectively eradicating healthcare professional’s exposure to potentially infectious liquids gathered during surgical and other medical operations. Soluble Biotech Inc. is involved in research focused on protein production, stability studies and solubility improvements. zPREDICTA, Inc carries out tumor-specific research using vitro models for oncology and drug development.

Forward-Looking Statements:
This press release comprises of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "expects," "plans," "intends," "anticipates," "believes," "estimates," "seeks," variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). The Company’s actual results may differ materially from the anticipated results reflected in these forward-looking statements.

PREDICTIVE ONCOLOGY INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

	March 31, 2022			December 31, 2021
	(unaudited)			(audited)
ASSETS
Current Assets:
Cash and Cash Equivalents	$	25,115,561		$		28,202,615
Accounts Receivable		264,966				354,196
Inventories		455,680				387,684
Prepaid Expense and Other Assets		408,102				513,778
Total Current Assets		26,244,309				29,458,273

Fixed Assets, net		2,335,692				2,511,571
Intangibles, net		3,893,438				3,962,118
Lease Right-of-Use Assets		651,921				814,454
Other Long-Term Assets		75,618				167,065
Goodwill		6,857,790				6,857,790
Total Assets	$	40,058,768		$		43,771,271

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts Payable	$	1,106,811		$		1,021,774
Accrued Expenses and other liabilities		695,416				1,262,641
Derivative Liability		127,572				129,480
Deferred Revenue		182,626				186,951
Lease Liability		568,825				639,662
Total Current Liabilities		2,681,250				3,240,508

Lease Liability – Net of current portion		133,926				239,664
Other long-term liabilities		63,098				25,415
Total Liabilities		2,878,274				3,505,587

Stockholders’ Equity:
Preferred Stock, 20,000,000 authorized inclusive of designated below
Series B Convertible Preferred Stock, $.01 par value, 2,300,000 shares authorized, 79,246 shares outstanding		792				792
Common Stock, $.01 par value, 200,000,000 shares authorized, 65,906,465 and 65,614,597 outstanding		659,065				656,146
Additional paid-in capital		167,931,634				167,649,028
Accumulated Deficit		(131,410,997	)			(128,040,282	)
Total Stockholders’ Equity		37,180,494				40,265,684

Total Liabilities and Stockholders’ Equity	$	40,058,768			$	43,771,271

PREDICTIVE ONCOLOGY INC.
CONDENSED CONSOLIDATED STATEMENTS OF NET LOSS
(Unaudited)

	Three Months Ended March 31,
	2022			2021
Revenue	$	314,568		$	280,317
Cost of goods sold		109,443			97,758
Gross margin		205,125			182,559
General and administrative expense		2,423,651			3,270,777
Operations expense		891,071			574,812
Sales and marketing expense		304,467			114,641
Total operating loss		(3,414,064	)		(3,777,671	)
Other income		42,430			28,259
Other expense		(989	)		(234,972	)
Gain on derivative instruments		1,908			95,671
Net loss	$	(3,370,715	)	$	(3,888,713	)

Loss per common share - basic and diluted	$	(0.05	)	$	(0.11	)

Weighted average shares used in computation - basic and diluted		65,835,080			36,513,300

Investor Relations Contact:

Landon Capital
Keith Pinder
(404) 995-6671
kpinder@landoncapital.net

EX-101.SCH 3 gnw-20190101.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 gnw-20190101_def.xml XBRL DEFINITION FILE EX-101.LAB 5 gnw-20190101_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 gnw-20190101_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	May 12, 2022
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	May 12, 2022
Entity File Number	001-36790
Entity Registrant Name	Predictive Oncology Inc.
Entity Central Index Key	0001446159
Entity Tax Identification Number	33-1007393
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	2915 Commers Drive, Suite 900
Entity Address, City or Town	Eagan
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55121
City Area Code	651
Local Phone Number	389-4800
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common stock, $0.01 par value
Trading Symbol	POAI
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

XML 8 f8k_051222_htm.xml IDEA: XBRL DOCUMENT 0001446159 2022-05-12 2022-05-12 iso4217:USD shares iso4217:USD shares 0001446159 false 8-K 2022-05-12 Predictive Oncology Inc. DE 001-36790 33-1007393 2915 Commers Drive, Suite 900 Eagan MN 55121 651 389-4800 false false false false Common stock, $0.01 par value POAI NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://globenewswire.com/role/Cover Cover Cover 1 false false All Reports Book All Reports f8k_051222.htm exh_991.htm gnw-20190101.xsd gnw-20190101_def.xml gnw-20190101_lab.xml gnw-20190101_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f8k_051222.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "gnw-20190101_def.xml" ] }, "inline": { "local": [ "f8k_051222.htm" ] }, "labelLink": { "local": [ "gnw-20190101_lab.xml" ] }, "presentationLink": { "local": [ "gnw-20190101_pre.xml" ] }, "schema": { "local": [ "gnw-20190101.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "gnw", "nsuri": "http://globenewswire.com/20190101", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "f8k_051222.htm", "contextRef": "Form8K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://globenewswire.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "f8k_051222.htm", "contextRef": "Form8K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 15 0001171843-22-003649-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-22-003649-xbrl.zip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